Market Cap

Delta-Fly Pharma, Inc. Market Capitalization:

¥7.22 Billion

JPY as of Jan. 1, 2024

US$51.3 Million

business Delta-Fly Pharma, Inc. Company Profile

Delta-Fly Pharma, Inc. Main Stock Listing

JPX: 4598

Market Capitalization History of Delta-Fly Pharma, Inc.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $461.52 B
Vertex Pharmaceuticals Incorporated $107.23 B
Regeneron Pharmaceuticals, Inc. $100.01 B
CSL Limited $94.74 B
Marinomed Biotech AG $73.23 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $586.39 B
UnitedHealth Group $504.47 B
Novo Nordisk $461.52 B
Johnson & Johnson $387.50 B
Merck $296.51 B

Yearly evolution of Delta-Fly Pharma, Inc. market cap

Date Market Cap YoY Change
Jan. 1, 2024 ¥7.22 B 9.76%
Jan. 1, 2023 ¥6.58 B 2.02%
Jan. 1, 2022 ¥6.45 B 6.34%
Jan. 1, 2021 ¥6.06 B -23.20%
Jan. 1, 2020 ¥7.90 B -46.92%
Jan. 1, 2019 ¥14.88 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +269.94%

$10,000 in May 2023 would now be $36,994 by following this algorithm daily at market close.

Boost your stocks returns with Disfold AI... Now!

Try Disfold AI for FREE

Delta-Fly Pharma, Inc. Categories

Japan languages Healthcare languages Biotechnology
Japan Healthcare Japan Biotechnology

Stocks & Indices

Delta-Fly Pharma, Inc. has the following listings and related stock indices.


Stock: JPX: 4598

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.